Clinical Trial Update: Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of an intravitreal dexamethasone implant in retinal vein occlusion patients after anti-VEGF injections. Results from the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Retina Macula Institute | Conditions: Retinal Vein Occlusion, Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2017-05-31